Clinical trial · Interventional
Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism.
NCT00573573CI-TRIAL-00002151unknownPhase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A study to determine the possibility of using far infrared radiation to treat Hyperparathyroidism.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hyperparathyroidism | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Far Infrared Radiation | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- 1
- interventionNames
- Radiation: Far Infrared Radiation
Primary outcomes (1)
- measure
- The primary end point is to determine the therapeutic effects of far infrared radiation on Hyperparathyroidism.
- timeFrame
- 2 years
Secondary outcomes (1)
- measure
- Effect of far infrared radiation treatment on other immune deficiency diseases like thyroidism and diabetes
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Persons with parathyroid disease Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.